Navigation Links
The International Myeloma Foundation Says Data Reported at a Global,Medical Meeting in Greece Demonstrates Improved Survival for a Wide,Range of Myeloma Patients

rable" responses with improved tolerability, even in patients who had stopped responding to either drug when used alone. The data presented this week showed a 100 percent response rate in newly diagnosed patients and a 68 percent response rate in relapsed patients.

"The number of options available to treat myeloma patients today is growing with positive results from mature studies, as well as preliminary results from smaller trials," said Brian G.M. Durie, M.D. chairman and co- founder of the IMF. "What we are learning from using these novel combinations in myeloma is so promising that our findings may become applicable to many malignancies including lung, ovarian and other cancers. The progress we've begun in myeloma is encouraging for all cancer patients around the world."

Myeloma, also called multiple myeloma, is a cancer of cells in the bone marrow that affects production of red cells, white cells and stem cells. It affects an estimated 750,000 people worldwide, and in industrialized countries it is being diagnosed in growing numbers and in increasingly younger people.

ABOUT THE INTERNATIONAL MYELOMA FOUNDATION

The International Myeloma Foundation is the oldest and largest myeloma organization, reaching more than 135,000 members in 113 countries worldwide. A 501 (c) 3 non-profit organization dedicated to improving the quality of life of myeloma patients and their families, the IMF focuses in four key areas: research, education, support and advocacy. To date, the IMF has conducted more than 120 educational seminars worldwide, maintains a world-renowned hotline, and operates Bank On A Cure(R), a unique gene bank to advance myeloma research. The IMF can be reached at (800) 452-CURE or http://www.myeloma.org, and in Spanish at http://www.myelomala.org.

Contact: Stephen Gendel

              The International Myel
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
6. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
7. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
8. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
9. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
10. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
11. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
Post Your Comments:
(Date:7/10/2014)... July 10, 2014  Breg, Inc., a premier ... launched the FreeRunner™ knee brace with new innovations ... patella mal-tracking return to active lifestyles.  FreeRunner,s patent-pending ... braces, providing support when patients need it most, ... don,t. Patellofemoral issues are the most ...
(Date:7/10/2014)... 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... completed the sale to Galderma of all rights to ... by Valeant for $1.4 billion in cash, pursuant to ... completed its acquisition of Galderma. "We ... to a company that is firmly committed to the ...
(Date:7/10/2014)... Mass. , July 10, 2014 Decision ... report awareness of the U.S. Food and Drug Administration,s ... new phosphate binder Velphoro, which was approved by the ... in chronic kidney disease (CKD) patients on dialysis. ... TreatmentTrends: Nephrology (US) Q2 2014 : ...
Breaking Medicine Technology:Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3
... The Medical Oncology Association of Southern California ... an agreement to work together to expand use ... costs of cancer care in Southern California. ... and distribution services to help health care professionals, ...
... The American Society of Bariatric Physicians (ASBP) is sad ... go out to his family, friends and fans.  The recent ... a contributing factor to his death are concerning and bring ... prescribed. While the specific details of Bubba ...
Cached Medicine Technology:Medical Oncology Association of Southern California, Cardinal Health Specialty Solutions Collaborate With Payors to Improve Quality, Costs, Accessibility of Cancer Care 2Medical Oncology Association of Southern California, Cardinal Health Specialty Solutions Collaborate With Payors to Improve Quality, Costs, Accessibility of Cancer Care 3Physicians Who Treat Obesity Respond to the News of Bubba Smith's Overdose 2
(Date:7/11/2014)... July 11, 2014 Wearing the school motto ... families, facility and staff came together this past Saturday morning ... Everest community in the Homer Township Independence Day Parade. ... Old Glory. , Everest community recognized the theme ... in red, white and blue. The blue Everest balloons ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Growing old was thought ... then. However, in recent studies, it was shown that many of ... credence behind them. As it turns out, the elderly can still ... , Of course, with all the time in the world, older ... them to indulge their passions in the twilight of their lives. ...
(Date:7/11/2014)... Newport Beach, CA (PRWEB) July 11, 2014 ... product pure Artichoke Leaf Extract dietary supplements to aid ... flow, an action necessary to facilitate metabolism of fat. ... facilities, Superior Labs Artichoke Leaf Extract is available in ... of pure artichoke extract. , Health Benefits of ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Plasma resource ... blood products industry. Although the closure of 16 plasma ... disruption to domestic blood products market, the total plasma ... year on year and total lot release volume declined ... to stock consumption, insufficient utilization of new plasma stations ...
(Date:7/11/2014)... New Mexico (PRWEB) July 11, 2014 ... stress disorder are just some of the increasing numbers ... them to lead more independent and productive lives. ... the workplace? Or is an assistance dog an impediment ... Assistance Dog Week , August 3 - 9, 2014, ...
Breaking Medicine News(10 mins):Health News:Everest Academy Participates in the Homer Township Independence Day Parade 2Health News:It’s All Free For Seniors Review, How To Take Advantage of What Life Has to Offer In Old Age – Vinamy.com 2Health News:It’s All Free For Seniors Review, How To Take Advantage of What Life Has to Offer In Old Age – Vinamy.com 3Health News:Artichoke Leaf Extract Released by SuperiorLabs Now Available on Amazon.com With 2 Day Prime Shipping 2Health News:Artichoke Leaf Extract Released by SuperiorLabs Now Available on Amazon.com With 2 Day Prime Shipping 3Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 2Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 3Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 4Health News:Will Your Next Employee or Co-Worker Be a Dog? 2Health News:Will Your Next Employee or Co-Worker Be a Dog? 3Health News:Will Your Next Employee or Co-Worker Be a Dog? 4
... Categories of Customer ... Satisfaction, According to MD Buyline, NASHUA, N.H., ... of Computer-Aided Detection (CAD),solutions for the early detection of ... satisfaction ratings in the,Mammography CAD market, according to the ...
... 29, 2008, Presenting at the BMO Capital Markets Focus ... ... LCA-Vision Inc. (Nasdaq:,LCAV), a leading provider of laser vision ... events., Second Quarter 2008 Financial Results, LCA-Vision will ...
... researchers report , , THURSDAY, July 10 (HealthDay News) ... damaged muscle in mice with a form of muscular ... skeletal muscle. , There,s no guarantee that the treatment ... author Amy Wagers, an assistant professor in Harvard University,s ...
... Many vitamin pills and tablets such as pain killers ... This will often incorporate some form of desiccant to ... in the tube stops the contents from rattling around. ... to lose and require two hands to manipulate. Customers ...
... Utah, July 10 Merit Medical,Systems, Inc. (Nasdaq: ... of,proprietary disposable devices used primarily in cardiology and ... quarter ended June,30, 2008 were approximately $57.4 million, ... 2007, which the Company believes will produce earnings ...
... Stand Behind Our ... Troops, ... creating awareness for the most underserved and,at-risk groups in our country, today ... is to assist those soldiers,who have been wounded in conflict in the ...
Cached Medicine News:Health News:iCAD Achieves Record-High Ratings in Mammography CAD User Satisfaction 2Health News:iCAD Achieves Record-High Ratings in Mammography CAD User Satisfaction 3Health News:LCA-Vision Announces Upcoming Investment Community Events 2Health News:Stem Cells Hold Promise for Muscular Dystrophy 2Health News:Integrated tube cap design simplifies access to medication 2Health News:Merit Medical Pre-Announces Record Sales and Earnings for the Second Quarter Ended June 30, 2008 2Health News:Merit Medical Pre-Announces Record Sales and Earnings for the Second Quarter Ended June 30, 2008 3Health News:Purple Dog Tag Launches; Provides Hope and Healing to Thousands of US Servicemen & Veterans 2
... Operation: , Double Burst : 2 60-ms bursts of ... s (1 pulse/s) , Tetanus: 50 Hz (50 ... Single (4 pulses/2 s) , Output Current: Adjustable from ... pulses (200-us duration) , Indicators: Battery LED (green) indicates ...
... of Operation: , Standby: A standby switch maintains ... , Twitch: 1 s (1 pulse/s) , ... (4 pulses/2 s) , Output Current: Adjustable from ... Monophasic pulses (200-us duration) , Indicators: Battery LED ...
Anesthesia Associates Model 100 Compact Peripheral Nerve Stimulator, incorporates the latest state-of-the-art electronics with solid state cicuitry to ensure trouble-free operation and extended batte...
... the newest peripheral nerve stimulator from B. Braun ... stimulators providing advanced digital technology. , ,Your ... HNS11 allows the localization of practically all mixed ... ,An additional optional component for the HNS11 ...
Medicine Products: